Summary of project PR000716

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000716. The data can be accessed directly via it's Project DOI: 10.21228/M8496H This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR000716
Project DOI:doi: 10.21228/M8496H
Project Title:Evaluation of TB Treatment Response Biomarkers
Project Type:Directed MS analysis
Project Summary:Directed MS analysis of promising treatment response biomarkers in TB patient urine.
Institute:Colorado State University
Department:Department of Microbiology, Immunology, and Pathology
Laboratory:Belisle
Last Name:Fitzgerald
First Name:Bryna
Address:3185 Rampart Rd, Fort Collins, CO, 80521, USA
Email:blfitz@colostate.edu
Phone:9704918905
Funding Source:NIH U01 AI-115619

Summary of all studies in project PR000716

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST001069 Evaluation of Seryl-leucine core 1 O-glycosylated peptide (SLC1G) in TB patient urine Homo sapiens Colorado State University MS 2018-12-11 1 229 Uploaded data (1.4G)*
ST001104 Seryl-leucine core 1 O-glycosylated peptide (SLC1G) identification Homo sapiens Colorado State University MS* 2019-01-22 1 9 Uploaded data (1.5G)*
  logo